admera_health_final_logo_transparent_final-100-3-300x122 Admera Health Homepage

Genetics for Smarter Medication Management

Admera Health provides
high-integrity end-to-end
pharmacogenomics solutions
PGxOnePlusPNG_logo_finalsmtm-1024x183 Admera Health Homepage

PGxOne™ Plus is a 60+ gene pharmacogenomics (PGx) test that can provide insight into how a patient will respond to certain drugs based on their DNA.

Built on the foundation of enabling the practice of smarter and safer healthcare, PGxOne™ Plus incorporates next-generation test design applications and expert data curation to deliver evidence-based medically actionable results.

8ae8ca5e-c998-453a-8ac9-27290eb1d81b Admera Health Homepage
PGxOnePlusPNG_logo_finalsmtm-300x53 Admera Health Homepage

PGxOne™ Plus is 62 a gene pharmacogenomics (PGx) test that can provide insight into how a patient will respond to certain drugs based on their DNA.

Built on the foundation of enabling the practice of smarter and safer healthcare, PGxOne™ Plus incorporates next-generation test design applications and expert data curation to deliver evidence-based medically actionable results.

8ae8ca5e-c998-453a-8ac9-27290eb1d81b Admera Health Homepage
Pharmacogenomics-1024x151 Admera Health Homepage

What is Pharmacogenomics?

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.
25aa0ab2-8d08-4d2c-a8d1-0d58d2930377 Admera Health Homepage
RxVisionPNG_logo_finalsmtm-300x72 Admera Health Homepage

Gain Additional Insight with RxVison™ 

In combination with RxVision™, Admera Health’s dynamic online reporting tool, the PGxOne™ Plus test delivers a complete PGx assessment for patient management solutions.
7ab1327b-3703-44de-b583-2c2a7af79bc6 Admera Health Homepage
How it Works

1

Sample_Type_Table_New-x2-e1598409425566 Admera Health Homepage

Provide a buccal swab,
mouth wash, blood,
or saliva sample

2

how_it_works_2 Admera Health Homepage

Ship the
specimen to
Admera Health

3

how_it_works_3 Admera Health Homepage

Admera Health
scientists sequence
and interpret DNA

4

how_it_works_4 Admera Health Homepage

Receive a
personalized
genetic report

Additional Precision Medicine Endeavors
From the lab bench to the clinic, Admera Health leverages existing knowledge and infrastructure to offer additional clinical services and robust Biopharma Services (BPS).

Clinical Services

a5775661-8e6b-48b9-b422-027acc0a720b Admera Health Homepage

AtheroGxOne™

Risk assessment for diseases that can cause early atherosclerosis.

CardioGxOne™

Potential diagnosis of over 30 inherited cardiovascular diseases.

OncoGxOne™

Comprehensive solid tumor profiling for targeted therapy selection.

Biopharma Services 

Admera Health’s Biopharma Services Department offers comprehensive genomics solutions for researchers worldwide.
2ff6a9cc-ecdc-4e79-b502-919079e46f33 Admera Health Homepage
CS_vert4.1Mobile-e1601314089149 Admera Health Homepage

Clinical Services

AtheroGxOne™

Risk assessment for diseases that can cause early atherosclerosis.
Learn More >

CardioGxOne™

Diagnose of over 30 inherited cardiovascular diseases.
Learn More >

OncoGxOne™

Solid tumor profiling for targeted therapy selection.
Learn More >

Latest News

Massive Bio to Present SYNERGY-AI Trial-in-Progress Poster Presentation at Upcoming AACR 2019 using its AI Clinical Trial Matching Technology, and Announces Strategic Partnership in Precision Oncology with US-Based Admera Health

NEW YORK, April 02, 2019 (GLOBE NEWSWIRE) -- Massive Bio, Inc., a leader in providing simplified and affordable access to clinical trials and precision oncology to cancer patients treated at community-based oncology practices, announced today that its Trials-in-Progress poster titled “SYNERGY-AI: Artificial intelligence based precision oncology clinical trial matching and [...]

Load More Posts
Go to Top